Form 4: Pulse Biosciences COO Buys Shares
Insider Transaction (Form 4)
Liane Rae Teplitsky, Chief Operating Officer of Pulse Biosciences, Inc., purchased 2,025 shares of common stock on August 31, 2026.
Summary
- Open-market purchase: acquired 1,024 Common Stock at $48.80 ($49,971) on August 31, 2026; holds 3,094 after (Direct).
- Open-market purchase: acquired 1,001 Common Stock at $49.95 ($50,000) on September 1, 2026; holds 4,095 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $99,971, committing personal capital to the stock.
Insider Transactions
Liane Rae Teplitsky — Officer (Chief Operating Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-31 | Open-market purchase | Common Stock | 1,024 | $49 | $50.0K | 3,094 |
| 2026-09-01 | Open-market purchase | Common Stock | 1,001 | $50 | $50.0K | 4,095 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-31 | Open-market purchase (1,024 shares) |
| 2026-09-01 | Open-market purchase (1,001 shares) |
Keywords
insider transaction, Form 4, PLSE, PULSE BIOSCIENCES, INC., bullish, Liane Rae Teplitsky
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.